Patent Watch

Premium

NPS Pharmaceuticals has been awarded US Patent 7,498,141, "Assay system for GLP-2 receptor ligands."

The inventors listed on the patent are Lidia Demchyshyn and Hong Wang.

The patent claims a method for measuring the contractility of intestinal tissue upon treatment with GLP-2 or a GLP-2 ligand, according to its abstract. Also described is an assay which directly measures the activity of GLP-2 or GLP-2 ligands ex vivo, and permits the screening of putative GLP-2 ligands in native tissue.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.